Marianna Müller

1.3k total citations
20 papers, 1.1k citations indexed

About

Marianna Müller is a scholar working on Oncology, Infectious Diseases and Physiology. According to data from OpenAlex, Marianna Müller has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 7 papers in Infectious Diseases and 6 papers in Physiology. Recurrent topics in Marianna Müller's work include Drug Transport and Resistance Mechanisms (17 papers), HIV/AIDS drug development and treatment (7 papers) and Adenosine and Purinergic Signaling (6 papers). Marianna Müller is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), HIV/AIDS drug development and treatment (7 papers) and Adenosine and Purinergic Signaling (6 papers). Marianna Müller collaborates with scholars based in United States, Hungary and France. Marianna Müller's co-authors include Balázs Sarkadi, Suresh V. Ambudkar, Zuben E. Sauna, András Váradi, Ervin Welker, Melissa M. Smith, Éva Bakos, Katalin Szabó, László Homolya and Kathleen Kerr and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Marianna Müller

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marianna Müller United States 16 903 398 273 252 181 20 1.1k
Zsolt Holló Hungary 15 1.1k 1.2× 583 1.5× 434 1.6× 221 0.9× 219 1.2× 20 1.5k
Carl A. Doige Canada 8 950 1.1× 466 1.2× 322 1.2× 235 0.9× 177 1.0× 8 1.1k
Krishnamachary Nandigama United States 14 730 0.8× 538 1.4× 209 0.8× 159 0.6× 140 0.8× 18 1.1k
Csilla Özvegy Hungary 7 541 0.6× 264 0.7× 177 0.6× 127 0.5× 133 0.7× 8 619
Stephen J. Currier United States 11 664 0.7× 413 1.0× 226 0.8× 173 0.7× 102 0.6× 11 874
Joseph W.K. Chu Canada 13 422 0.5× 341 0.9× 149 0.5× 118 0.5× 81 0.4× 20 695
Melvin S. Center United States 16 918 1.0× 716 1.8× 325 1.2× 160 0.6× 168 0.9× 21 1.3k
Bruce Dickstein United States 14 573 0.6× 327 0.8× 152 0.6× 165 0.7× 76 0.4× 20 949
Manfred G. Ismair Switzerland 12 957 1.1× 272 0.7× 485 1.8× 126 0.5× 174 1.0× 15 1.3k

Countries citing papers authored by Marianna Müller

Since Specialization
Citations

This map shows the geographic impact of Marianna Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianna Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianna Müller more than expected).

Fields of papers citing papers by Marianna Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianna Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianna Müller. The network helps show where Marianna Müller may publish in the future.

Co-authorship network of co-authors of Marianna Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Marianna Müller. A scholar is included among the top collaborators of Marianna Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianna Müller. Marianna Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iyer, Swaminathan P., Sabarish Ayyappan, Irl Brian Greenwell, et al.. (2023). Strategies to Develop Anti-KIR Mab Lacutamab in Patients with Peripheral T-Cell Lymphoma: Preliminary Monotherapy Clinical Data and Pre-Clinical Combinability Data. Blood. 142(Supplement 1). 3072–3072. 1 indexed citations
2.
Demaria, Olivier, Guillaume Habif, Marianna Müller, et al.. (2023). S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS. HemaSphere. 7(S3). e1234532–e1234532.
3.
Bagot, M., Youn H. Kim, Pablo L. Ortiz‐Romero, et al.. (2022). Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial. Blood. 140(Supplement 1). 3760–3761. 4 indexed citations
4.
Telbisz, Ágnes, Marianna Müller, Csilla Özvegy‐Laczka, et al.. (2007). Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(11). 2698–2713. 117 indexed citations
5.
Müller, Marianna, Izabella Klein, Alan T. Remaley, et al.. (2006). Co‐expression of human ABCG5 and ABCG8 in insect cells generates an androstan stimulated membrane ATPase activity. FEBS Letters. 580(26). 6139–6144. 9 indexed citations
8.
Müller, Marianna, et al.. (2002). Evidence for the Role of Glycosylation in Accessibility of the Extracellular Domains of Human MRP1 (ABCC1). Biochemistry. 41(31). 10123–10132. 46 indexed citations
9.
Sauna, Zuben E., Melissa M. Smith, Marianna Müller, & Suresh V. Ambudkar. (2001). Functionally Similar Vanadate-induced 8-Azidoadenosine 5′-[α-32P]Diphosphate-trapped Transition State Intermediates of Human P-glycoprotein Are Generated in the Absence and Presence of ATP Hydrolysis. Journal of Biological Chemistry. 276(24). 21199–21208. 28 indexed citations
10.
Sauna, Zuben E., Melissa M. Smith, Marianna Müller, & Suresh V. Ambudkar. (2001). Evidence for the Vectorial Nature of Drug (Substrate)-stimulated ATP Hydrolysis by Human P-glycoprotein. Journal of Biological Chemistry. 276(36). 33301–33304. 17 indexed citations
11.
Sauna, Zuben E., Melissa M. Smith, Marianna Müller, Kathleen Kerr, & Suresh V. Ambudkar. (2001). The Mechanism of Action of Multidrug-Resistance-Linked P-Glycoprotein. Journal of Bioenergetics and Biomembranes. 33(6). 481–491. 141 indexed citations
12.
Sharom, Frances J., Xiaohong Yu, Peihua Lu, et al.. (1999). Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. Biochemical Pharmacology. 58(4). 571–586. 90 indexed citations
13.
Holló, Zsolt, László Homolya, Tamás Hegedűs, et al.. (1998). Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1.. PubMed. 18(4C). 2981–7. 23 indexed citations
14.
Szabó, Katalin, Ervin Welker, Éva Bakos, et al.. (1998). Drug-stimulated Nucleotide Trapping in the Human Multidrug Transporter MDR1. Journal of Biological Chemistry. 273(17). 10132–10138. 76 indexed citations
15.
Sarkadi, Balázs & Marianna Müller. (1997). Search for specific inhibitors of multidrug resistance in cancer. Seminars in Cancer Biology. 8(3). 171–182. 48 indexed citations
16.
Szabó, Katalin, Éva Bakos, Ervin Welker, et al.. (1997). Phosphorylation Site Mutations in the Human Multidrug Transporter Modulate Its Drug-stimulated ATPase Activity. Journal of Biological Chemistry. 272(37). 23165–23171. 49 indexed citations
17.
Bakos, Éva, Izabella Klein, Ervin Welker, et al.. (1997). Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region. Biochemical Journal. 323(3). 777–783. 49 indexed citations
18.
Müller, Marianna, Éva Bakos, Ervin Welker, et al.. (1996). Altered Drug-stimulated ATPase Activity in Mutants of the Human Multidrug Resistance Protein. Journal of Biological Chemistry. 271(4). 1877–1883. 137 indexed citations
19.
Sarkadi, Balázs, Marianna Müller, & Zsolt Holló. (1996). The multidrug transporters—proteins of an ancient immune system. Immunology Letters. 54(2-3). 215–219. 22 indexed citations
20.
Sarkadi, Balázs, Marianna Müller, László Homolya, et al.. (1994). Interaction of bioactive hydrophobic peptides with the human multidrug transporter. The FASEB Journal. 8(10). 766–770. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026